We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-0.93%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.52B
AUM Growth
-$149M
Cap. Flow
-$56.4M
Cap. Flow %
-3.71%
Top 10 Hldgs %
43.87%
Holding
86
New
7
Increased
23
Reduced
23
Closed
3

Top Buys

Rank Stock Value
1
BCYC
Bicycle Therapeutics
BCYC
+$25.6M
2
PHLT
Performant Healthcare Inc
PHLT
+$19.6M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$19.2M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$15.7M
5
MXCT icon
MaxCyte
MXCT
+$15M

Top Sells

Rank Stock Value
1
ARWR icon
Arrowhead Research
ARWR
+$38.6M
2
GKOS icon
Glaukos
GKOS
+$34.7M
3
PRTA icon
Prothena Corp
PRTA
+$29.7M
4
HALO icon
Halozyme
HALO
+$23.9M
5
GMAB icon
Genmab
GMAB
+$15.6M

Sector Composition

Rank Sector Weight
1 Healthcare 80.69%
2 Communication Services 5.47%
3 Consumer Discretionary 0.55%
4 Energy 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIRO
51
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$3.31M 0.22%
475,000
– –
SLP icon
52
Simulations Plus
SLP
$369M
$2.97M 0.2%
75,123
-709
-0.9% -$32.4K
LHCG
53
DELISTED
LHC Group LLC
LHCG
$2.39M 0.16%
15,259
-163
-1% -$30.6K
RLAY icon
54
Relay Therapeutics
RLAY
$4.1B
$1.64M 0.11%
51,848
-338,707
-87% -$11.4M
NARI
55
DELISTED
Inari Medical, Inc. Common Stock
NARI
$952K 0.06%
+11,734
New +$986K
HRC
56
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$652K 0.04%
4,346
– –
AVTR icon
57
Avantor
AVTR
$9.32B
$597K 0.04%
14,596
– –
WAT icon
58
Waters Corp
WAT
$37B
$549K 0.04%
1,536
– –
ITGR icon
59
Integer Holdings
ITGR
$4.12B
$522K 0.03%
5,846
– –
SYNH
60
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$502K 0.03%
5,736
– –
NVST icon
61
Envista
NVST
$4.44B
$493K 0.03%
11,793
– –
GSK icon
62
GSK
GSK
$104B
$480K 0.03%
10,059
– –
BAX icon
63
Baxter International
BAX
$13.5B
$477K 0.03%
5,929
– –
ICUI icon
64
ICU Medical
ICUI
$4.21B
$476K 0.03%
2,039
– –
NUVA
65
DELISTED
NuVasive, Inc.
NUVA
$470K 0.03%
7,850
– –
CVS icon
66
CVS Health
CVS
$133B
$468K 0.03%
5,519
– –
GILD icon
67
Gilead Sciences
GILD
$162B
$468K 0.03%
6,705
– –
PRGO icon
68
Perrigo
PRGO
$1.4B
$465K 0.03%
9,823
– –
BDX icon
69
Becton Dickinson
BDX
$45.6B
$464K 0.03%
1,935
– –
ELV icon
70
Elevance Health
ELV
$81.5B
$464K 0.03%
1,244
– –
UTHR icon
71
United Therapeutics
UTHR
$25.8B
$455K 0.03%
2,466
– –
HOLX
72
DELISTED
Hologic
HOLX
$431K 0.03%
5,845
– –
BMY icon
73
Bristol-Myers Squibb
BMY
$133B
$429K 0.03%
7,256
– –
TAK icon
74
Takeda Pharmaceutical
TAK
$54.6B
$420K 0.03%
25,630
– –
HUM icon
75
Humana
HUM
$43.7B
$416K 0.03%
1,068
– –
1 2
3
4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, First Light Asset Management held 86 positions worth $1.52B, down 8.9% from $1.67B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

First Light Asset Management withdrew a net $56.4M in Q3 2021, closing 3 positions and reducing 23 holdings. Its most notable exit was Arrowhead Research, an estimated $38.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 84% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, First Light Asset Management opened a new position in Bicycle Therapeutics worth $30.5M.

  • First Light Asset Management's largest Q3 2021 buy was Bicycle Therapeutics: 732,731 shares worth $30.5M.
  • First Light Asset Management added most to Ultragenyx Pharmaceutical in Q3 2021, an estimated $19.2M increase.
  • First Light Asset Management's biggest Q3 2021 reduction was Prothena Corp, cutting an estimated $29.7M.
  • First Light Asset Management fully exited Arrowhead Research in Q3 2021, selling an estimated $38.6M.
  • First Light Asset Management's ten largest holdings make up 44% of its $1.52B portfolio in Q3 2021.
  • First Light Asset Management opened 7 new positions and closed 3 in Q3 2021.
  • First Light Asset Management's portfolio value fell 8.9% quarter-over-quarter to $1.52B.

Based on First Light Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.